Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification (Q46527475)

22 December 2017

title

Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification (English)

1 reference

22 December 2017

2

Roger Pique-Regi

0 references

author name string

Shahab Asgharzadeh

1

1 reference

22 December 2017

Richard Sposto

3

1 reference

22 December 2017

Hong Wang

4

1 reference

22 December 2017

Yujun Yang

5

1 reference

22 December 2017

Hiroyuki Shimada

6

1 reference

22 December 2017

Katherine Matthay

7

1 reference

22 December 2017

Jonathan Buckley

8

1 reference

22 December 2017

Antonio Ortega

9

1 reference

22 December 2017

Robert C Seeger

10

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

22 December 2017

Journal of the National Cancer Institute

published in

1 reference

22 December 2017

volume

98

1 reference

22 December 2017

issue

17

1 reference

22 December 2017

page(s)

1193-1203

1 reference

22 December 2017

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Molecular biology of neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Chromosome 1p and 11q deletions and outcome in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Diagnosis of multiple cancer types by shrunken centroids of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Expression and function of TRK-B and BDNF in human neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Identification and characterization of FLJ10737 and CAMTA1 genes on the commonly deleted region of neuroblastoma at human chromosome 1p36.31-p36.23

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Clinical trial designs for predictive marker validation in cancer treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Hyperdiploidy Plus NonamplifiedMYCNConfers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Expression of the Gene for Multidrug-Resistance–Associated Protein and Outcome in Patients with Neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJJ330

1 reference

22 December 2017

PubMed ID

16954472

1 reference

22 December 2017